共 50 条
- [1] Lenalidomide is effective and safe for the treatment of patients with relapsed multiple myeloma and very severe renal impairment Annals of Hematology, 2016, 95 : 931 - 936
- [3] Lenalidomide in combination with dexamethasone: effective regimen in patients with relapsed or refractory multiple myeloma complicated by renal impairment Annals of Hematology, 2011, 90 : 429 - 439
- [8] Lenalidomide plus low-dose dexamethasone in Chinese patients with relapsed or refractory multiple myeloma and renal impairment International Journal of Hematology, 2015, 101 : 569 - 577